Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 12/2019

01-12-2019 | Obesity | Original Contributions

A Spanish Society joint SECO and SEEDO approach to the Post-operative management of the patients undergoing surgery for obesity

Authors: R Vilallonga, JL Pereira-Cunill, S Morales-Conde, I Alarcón, I Breton, E Domínguez-Adame, JV Ferrer, A Garcia Ruiz-de-Gordejuela, A Goday, A Lecube, E Martín García-Almenta, MÁ Rubio, FJ Tinahones, PP García-Luna

Published in: Obesity Surgery | Issue 12/2019

Login to get access

Abstract

Purpose

Bariatric surgery is the method of choice for the management or treatment of obesity. Bariatric surgery brings about several physiological changes in the body and is associated with set of complications. The aim of this study is to provide guidelines on post bariatric surgery management based on consensus by the Spanish society for Obesity Surgery (Sociedad Española de Cirugía de la Obesidad) (SECO) and the Spanish Society for the Study of Obesity (Sociedad Española para el Estudio de la Obesidad) (SEEDO).

Method

The boards proposed seven experts from each society. The experts provided the evidence and a grade of recommendation on the selected topics based on systematic reviews/meta-analysis. A list of clinical practical recommendations levels of evidence and grades of these recommendations was derived from the consensus statements from the members of these societies.

Results

Seventeen topics related to post-operative management were reviewed after bariatric surgery. The experts came with 47 recommendations and statements. The mean number of persons voting at each statement was 54 (range 36-76).

Conclusion

In this consensus, we have designed a set of guidelines to be followed while managing patients after bariatric surgery. Expertise and knowledge of the clinicians are required to convey suitable considerations to the post-bariatric patients. There should also be extensive follow-up plans for the bariatric surgery patients.
Literature
1.
2.
Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219–34.PubMed
3.
Lopez-de-Andres A, Jiménez-García R, Hernández-Barrera V, et al. Trends in utilization and outcomes of bariatric surgery in obese people with and without type 2 diabetes in Spain (2001–2010). Diabetes Res Clin Pract. 2013;99:300–6.PubMed
4.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric Surgery Worldwide 2013. Obes Surg. 2015;25:1822–32.PubMed
5.
Isom KA, Andromalos L, Ariagno M, et al. Nutrition and metabolic support recommendations for the bariatric patient. Nutr Clin Pract. 2014;29:718–39.PubMed
6.
Rubio MA, Martínez C, Vidal O, et al. Documento de consenso sobre cirugía bariátrica. Rev Esp Obes. 2004;4:223–49.
7.
Heber D, Greenway FL, Kaplan LM, et al. Still C; Endocrine Society.Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4823–43.PubMed
8.
Fried M, Yumuk V, Oppert JM, et al. Frühbeck G; International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC); European Association for the Study of Obesity (EASO); European Association for the Study of Obesity Obesity Management Task Force (EASO OMTF). Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24:42–55.PubMed
9.
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013;21(Suppl 1):S1–27.
10.
Jericó C, Bretón I. García Ruiz de Gordejuela A, de Oliveira AC, Rubio MÁ, Tinahones FJ, Vidal J, Vilarrasa N. Diagnóstico y tratamiento del déficit de hierro, con o sin anemia, pre y poscirugía bariátrica. Endocrinol Nutr. 2016;63:32–42.PubMed
11.
Alexandrou A, Armeni E, Kouskouni E, et al. Lambrinoudaki I Cross-sectional long-term micronutrient deficiencies after sleeve gastrectomy versus Roux-en-Y gastric bypass: a pilot study. Surg Obes Relat Dis. 2014;10:262–8.PubMed
12.
Weng TC, Chang CH, Dong YH, et al. Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. BMJ Open. 2015;5:e006964.PubMedPubMedCentral
13.
Majumder S, Soriano J, Louie Cruz A, et al. Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations. Surg Obes Relat Dis. 2013;9:1013–9.PubMed
14.
Kwon Y, Kim HJ, Lo Menzo E, et al. Anemia, iron and vitamin B12 deficiencies after sleeve gastrectomy compared to Roux-en-Y gastric bypass: a meta-analysis. Surg Obes Relat Dis. 2014;10:589–97.PubMed
15.
Smelt HJ, Pouwels S, Smulders JF. Different Supplementation Regimes to Treat Perioperative Vitamin B12 Deficiencies in Bariatric Surgery: a Systematic Review. Obes Surg. 2017;27:254–62.
16.
Schafer AL, Weaver CM, Black DM, et al. Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status. J Bone Miner Res. 2015;30:1377–85.PubMed
17.
Chakhtoura MT, Nakhoul NN, Shawwa K, et al. Hypovitaminosis D in bariatric surgery: A systematic review of observational studies. Metabolism. 2016;65:574–85.PubMed
18.
Homan J, Ruinemans-Koerts J, Aarts EO, et al. Management of vitamin K deficiency after biliopancreatic diversion with or without duodenal switch. Surg Obes Relat Dis. 2016;12:338–44.PubMed
19.
Nett P, Borbély Y, Kröll D. Micronutrient Supplementation after Biliopancreatic Diversion with Duodenal Switch in the Long Term. Obes Surg. 2016;26:2469–74.PubMed
20.
Moore CE, Sherman V. Vitamin D supplementation efficacy: sleeve gastrectomy versus gastric bypass surgery. Obes Surg. 2014;24:2055–60.PubMed
21.
Chakhtoura MT, Nakhoul N, Akl EA, et al. Guidelines on vitamin D replacement in bariatric surgery: Identification and systematic appraisal. Metabolism. 2016;65:586–97.PubMedPubMedCentral
22.
de Luis DA, Pacheco D, Izaola O, et al. Zinc and copper serum levels of morbidly obese patients before and after biliopancreatic diversion: 4 years of follow-up. J Gastrointest Surg. 2011;15:2178–81.PubMed
23.
Boldery R, Fielding G, Rafter T, et al. Nutritional deficiency of selenium secondary to weight loss (bariatric) surgery associated with life-threatening cardiomyopathy. Heart Lung Circ. 2007;16:123–6.PubMed
24.
Moizé V, Andreu A, Flores L, et al. Long-term dietary intake and nutritional deficiencies following sleeve gastrectomy or Roux-En-Y gastric bypass in a mediterranean population. J Acad Nutr Diet. 2013;113:400–10.PubMed
25.
Balsa JA, Botella-Carretero JI, Gómez-Martín JM, et al. Copper and zinc serum levels after derivative bariatric surgery: differences between Roux-en-Y gastric bypass and biliopancreatic diversion. Obes Surg. 2011;21:744–50.PubMed
26.
Kumar P, Hamza N, Madhok B, et al. Copper Deficiency after Gastric Bypass for Morbid Obesity: a Systematic Review. Obes Surg. 2016;26:1335–42.PubMed
27.
Mahawar KK, Bhasker AG, Bindal V, et al. Zinc Deficiency after Gastric Bypass for Morbid Obesity: a Systematic Review. Obes Surg. 2017;27:522–9.
28.
Allied Health Sciences Section Ad Hoc Nutrition Committee, Aills L, Blankenship J, et al. ASMBS Allied Health Nutritional Guidelines for the Surgical Weight Loss Patient. Surg Obes Relat Dis. 2008;4(5 Suppl):S73–108.
29.
Gillon S, Jeanes YM, Andersen JR, et al. Micronutrient Status in Morbidly Obese Patients Prior to Laparoscopic Sleeve Gastrectomy and Micronutrient Changes 5 years Post-surgery. Obes Surg. 2017;27:606–12.
30.
Scopinaro N, Marinari GM, Pretolesi F, et al. Energy and nitrogen absorption after biliopancreatic diversion. Obes Surg. 2000;10:436–41.PubMed
31.
Handzlik-Orlik G, Holecki M, Orlik B, et al. Nutrition management of the post-bariatric surgery patient. Nutr Clin Pract. 2015;30:383–92.PubMed
32.
Moizé V, Andreu A, Rodríguez L, et al. Protein intake and lean tissue mass retention following bariatric surgery. Clin Nutr. 2013;32:550–5.PubMed
33.
Andreu A, Moizé V, Rodríguez L, et al. Protein intake, body composition, and protein status following bariatric surgery. Obes Surg. 2010;20:1509–15.PubMed
34.
Schollenberger AE, Karschin J, Meile T, et al. Impact of protein supplementation after bariatric surgery: A randomized controlled double-blind pilot study. Nutrition. 2016;32:186–92.PubMed
35.
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013;9:159–91.PubMed
36.
Yumuk V, Tsigos C, Fried M, et al. Toplak H; Obesity Management Task Force of the European Association for the Study of Obesity. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8:402–24.PubMedPubMedCentral
37.
Díez I, Martínez C, Sánchez-Santos R, Ruiz JC, Frutos MD, De la Cruz F et al. RecomendacionesRecomendaciones de la SECO para la práctica de la cirugía bariátrica y metabólica (Declaración de Vitoria-Gasteiz,
38.
Thorell A, Hagström-Toft E. Treatment of diabetes prior to and after bariatric surgery. J Diabetes Sci Technol. 2012;6:1226–32.PubMedPubMedCentral
39.
Panunzi S, Carlsson L, De Gaetano A, et al. Determinants of Diabetes Remission and Glycemic Control After Bariatric Surgery. Diabetes Care. 2016;39:166–74.PubMed
40.
Miller GD, Hale E, Dunlap G. Current Evidence for Physical Activity in the Bariatric Surgery Patient for Weight Loss Success. J Obes Weight Loss Ther. 2015;5:274.
41.
42.
Lecube A, Monereo S, Rubio MÁ, et al. Prevention, diagnosis, and treatment of obesity. 2016 position statement of the Spanish Society for the Study of Obesity. Endocrinol Diabetes Nutr. 2017;64(Suppl 1):15–22.
43.
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract. 2013;19:337–72.PubMedPubMedCentral
44.
Greestein AJ, O’Rourke RW. Abdominal pain after gastric bypass: suspects and solutions. Am J Surg. 2011;201:819–27.
45.
Sarwer DB, Dilks RJ, West-Smith L. Dietary intake and eating behaviour after bariatric surgery: threats to weight loss maintenance and strategies for success. Surg Obes Relat Dis. 2011;7:644–51.PubMed
46.
Pedersen JS, Borup C, Damgaard M, et al. Gadsbøll N Early 24-hour blood pressure response to Roux-en-Y gastric bypass in obese patients. Scand J Clin Lab Invest. 2017;77:53–9.PubMed
47.
Benaiges D, Sagué M, Flores-Le Roux JA, et al. Predictors of Hypertension Remission and Recurrence After Bariatric Surgery. Am J Hypertens. 2016;29:653–9.PubMed
48.
Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169:91–6. discussion 96-7PubMed
49.
Adams LB, Chang C, Pope J, et al. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy. Obes Surg. 2016;26:990–4.PubMed
50.
Coupaye M, Calabrese D, Sami O, et al. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid. Surg Obes Relat Dis. 2017;13:681–685.PubMed
51.
Abdallah E, Emile SH, Elfeki H, et al. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy. Surg Today. 2017;47:844–50.PubMed
52.
Stokes CS, Gluud LL, Casper M, et al. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. ClinGastroenterolHepatol. 2014;12:1090–1100.e2.
53.
Uy MC, Talingdan-Te MC, Espinosa WZ, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg. 2008;18:1532–8.PubMed
54.
Coblijn UK, Lagarde SM, de Castro SM, et al. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study. Surg Obes Relat Dis. 2016;12:246–52.PubMed
55.
Tsirline VB, Keilani ZM, El Djouzi S, et al. How frequently and when do patients undergo cholecystectomy after bariatric surgery? Surg Obes Relat Dis. 2014;10:313–21.PubMed
56.
Stenberg E, Szabo E, Ågren G, et al. Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial. Lancet. 2016;387:1397–404.PubMed
57.
Chang J, Corcelles R, Boules M, et al. Predictive factors of biliary complications after bariatric surgery. Surg Obes Relat Dis. 2016;12:1706–10.PubMed
58.
Lockhart ME, Tessler FN, Canon CL, et al. Internal hernia after gastric bypass: sensitivity and specificity of seven CT signs with surgical correlation and controls. AJR Am J Roentgenol. 2007;188:745–50.PubMed
59.
Gandhi AD, Patel RA, Brolin RE. Elective laparoscopy for herald symptoms of mesenteric/internal hernia after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5:144–9. discussion 149PubMed
60.
Doraiswamy A, Rasmussen JJ, Pierce J, et al. The utility of routine postoperative upper GI series following laparoscopic gastric bypass. Surg Endosc. 2007;21:2159.PubMed
61.
White S, Han SH, Lewis C, et al. Selective approach to use of upper gastroesophageal imaging study after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4:122.PubMed
62.
Kolakowski Jr S, Kirkland ML, Schuricht AL. Routine postoperative upper gastrointestinal series after Roux-en-Y gastric bypass: determination of whether it is necessary. Arch Surg. 2007;142:930.PubMed
63.
Brown WA, Egberts KJ, Franke-Richard D, et al. Erosions after laparoscopic adjustable gastric banding: diagnosis and management. Ann Surg. 2013;257:1047–52.PubMed
64.
Dixon JB, Bhasker AG, Lambert GW, et al. Leg to leg bioelectrical impedance analysis of percentage fat mass in obese patients-Can it tell us more than we already know? Surg Obes Relat Dis. 2016;12:1397–402.PubMed
65.
Vassilev G, Hasenberg T, Krammer J, et al. The Phase Angle of the Bioelectrical Impedance Analysis as Predictor of Post-Bariatric Weight Loss Outcome. Obes Surg. 2017;27:665–9.
66.
Faria SL, Faria OP, Cardeal MD, et al. Validation study of multi-frequency bioelectrical impedance with dual-energy X-ray absorptiometry among obese patients. Obes Surg. 2014;24:1476–80.PubMed
67.
Widen EM, Strain G, King WC, et al. Validity of bioelectrical impedance analysis for measuring changes in body water and percent fat after bariatric surgery. Obes Surg. 2014;24:847–54.PubMedPubMedCentral
68.
Jiménez A, Omaña W, Flores L, et al. Prediction of whole-body and segmental body composition by bioelectrical impedance in morbidly obese subjects. Obes Surg. 2012;22:587–93.
69.
O'Brien PE, MacDonald L, Anderson M, et al. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257:87–94.PubMed
70.
Sims TL, Mullican MA, Hamilton EC, et al. Routine upper gastrointestinal Gastrografin swallow after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13:66.PubMed
71.
Schiesser M, Guber J, Wildi S, et al. Utility of routine versus selective upper gastrointestinal series to detect anastomotic leaks after laparoscopic gastric bypass. Obes Surg. 2011;21:1238–42.PubMed
72.
Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term outcomes of bariatric surgery: national institutes of health symposium. JAMA Surg. 2014;149:1323–9.PubMedPubMedCentral
73.
Walsh C, Karmali S. Endoscopic management of bariatric complica¬tions: a review and update. World J Gastrointest Endosc. 2015;7:518–23.PubMedPubMedCentral
74.
De Roover A, Detry O, Desaive C, et al. Risk of Upper Gastrointestinal Cancer after Bariatric Operations. Obes Surg. 2006;16(12):1656–61.PubMed
75.
Schirmer B, Erenoglu C, Miller A. Flexible Endoscopy in the Management of Patients Undergoing Roux-en-Y Gastric Bypass. Obes Surg. 2002;12(5):634–8.PubMed
76.
Spinosa SR, Valezi AC. Endoscopic Findings of Asymptomatic Patients One Year After Roux-en-Y Gastric Bypass for Treatment of Obesity. Obes Surg. 2013;23(9):1431–5.PubMed
77.
Joo MK. Endoscopic Approach for Major Complications of Bariatric Surgery. Clin Endosc. 2017;50:31–41.PubMed
78.
Walsh C, Karmali S. Endoscopic management of bariatric complications: A review and update. World J Gastrointest Endosc. 2015;7:518–23.PubMedPubMedCentral
79.
Valli PV, Gubler C. Review article including treatment algorithm: endoscopic treatment of luminal complications after bariatric surgery. Clin Obes. 2017;7:115–22.PubMed
80.
Stein EM, Silverberg SJ. Bone loss after bariatric surgery: causes, consequences, and management. Lancet Diabetes Endocrinol. 2014;2:165–74.PubMedPubMedCentral
81.
Rousseau C, Jean S, Gamache P, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ. 2016;354:i3794.PubMedPubMedCentral
82.
Kim J. Brethauer S; ASMBS Clinical Issues Committee.; American Society for Metabolic and Bariatric Surgery Clinical Issues Committee, Position Statement.. Metabolic bone changes after bariatric surgery. Surg Obes Relat Dis. 2015;11:406–11.PubMed
83.
Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17:565–8.PubMed
84.
Baltasar A, Perez N, Serra C, et al. Weight loss reporting: predicted body mass index after bariatric surgery. Obes Surg. 2011;21:367–72.PubMed
85.
Vilallonga R, van de Vrande S, Himpens J. Laparoscopic reversal of Roux-en-Y gastric bypass into normal anatomy with or without sleeve gastrectomy. Surg Endosc. 2013;27:4640–8.PubMed
86.
Ferraz A, Campos J, Dib V, et al. Food intolerance after banded gastric bypass without stenosis: aggressive endoscopic dilation avoids reoperation. Obes Surg. 2013;23:959–64.PubMed
87.
Abu Dayyeh BK, Lautz DB, Thompson CC. Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass. Clin Gastroenterol Hepatol. 2011;9:228–33.PubMed
88.
Quigley S, Colledge J, Mukherjee S, et al. Bariatric surgery: A review of normal postoperative anatomy and complications. Clin Radiol. 2011;66:903–14.PubMed
89.
Vasas P, Dillemans B, Van Cauwenberge S, et al. Short- and long-term outcomes of vertical banded gastroplasty converted to Roux-en-Y gastric bypass. Obes Surg. 2013;23:241–8.
90.
Marins CJ, Moon RC, Magalhães Neto GEJ, et al. Endoscopic treatment of food intolerance after a banded gastric bypass: inducing band erosion for removal using a plastic stent. Endoscopy. 2016;48:516–20.PubMed
91.
Júnior WS, Campos CS, Nonino BS. Reporting results after bariatric surgery: reproducibility of predicted body mass index. Obes Surg. 2012;22:519–22.PubMed
92.
Van de Laar A. Bariatric Outcomes Longitudinal Database (BOLD) suggests excess weight loss and excess BMI loss to be inappropriate outcome measures, demonstrating better alternatives. Obes Surg. 2012;22:1843–7.PubMed
93.
Sczepaniak JP, Owens ML, Shukla H, et al. Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD data 2008-2011. Obes Surg. 2015;25:788–95.PubMed
94.
Warschkow R, Tarantino I, Ukegjini K, Beutner U, Güller U, Schmied BM, Müller SA, Schultes B, Thurnheer M. Concomitant cholecystectomy during laparoscopic Rouxen-Y gastric bypass in obese patients is not justified: a meta-analysis. Obes Surg. 2013;23:397–407.PubMed
95.
Moon RC, Teixeira AF, DuCoin C, et al. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding. Surg Obes Relat Dis. 2014;10:64–8.PubMed
96.
Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24:299–309.
97.
Sverden E, Mattson F, Sonden A, et al. Risk factors for marginal ulcer after Gastric Bypass Surgery: a population based cohorte. Ann Surg. 2016;263:733–7.
98.
Moon RC, Teixeira AF, Jawad MA. Management and treatment outcomes of marginal ulcers after Roux-en-Y gastric bypass at a single high volume bariatric center. Surg Obes Relat Dis. 2014;10:229–34.PubMed
99.
Carr WR, Mahawar KK, Balupuri S, et al. An evidence-based algorithm for the management of marginal ulcers following Roux-en-Y gastric bypass. Obes Surg. 2014;24:1520–7.PubMed
100.
101.
Warschkow R, Tarantino I, Ukegjini K, Beutner U, Güller U, Schmied BM, Müller SA, Schultes B, Thurnheer M. Concomitant cholecystectomy during laparoscopic Rouxen-Y gastric bypass in obese patients is not justified: a meta-analysis. Obes Surg. 2013;23:397–407.PubMed
102.
Brolin RE, Cody RP. Weight loss outcome of revisional bariatric operations varies according to the primary procedure. Ann Surg. 2008;248:227–32.PubMed
103.
Brethauer SA, Kothari S, Sudan R, et al. Systematic review on reoperative bariatric surgery: American Society for Metabolic and Bariatric Surgery Revision Task Force. Surg Obes Relat Dis. 2014;10:952–72.PubMed
104.
Management for Failed Bariatric Procedures: Surgical Strategies. New York: Nova Publishers; 2015. J. Himpens & R. Vilallonga (978-1-63483-753-8)
105.
Swartz E, Mobley E, Felix EL. Bile reflux after Roux en Y gastric bypass: an unreconized cause of posoperative pain. Surg Obes Relat Dis. 2009;5:27–30.PubMed
106.
Scozari TR, Toppino M, et al. Esophafogastric cancer after bariatric surgery; systematic review of the literature. Surg Obes Relat Dis. 2013;9:133–42.
107.
108.
Balibrea JM, Vilallonga R, Hidalgo M, et al. Mid-Term Results and Responsiveness Predictors After Two-Step Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy. Obes Surg. 2017;27:1302–8.
109.
Coakley BA, Deveney CW, Spight DH, Thompson SK, Le D, Jobe BA, Wolfe BM, McConnell DB, O'Rourke RW. Revisional bariatric surgery for failed restrictive procedures. Surg Obes Relat Dis. 2008;4:581–6.PubMed
110.
Patel LY, Lapin B, Brown CS, et al. Outcomes following 50 consecutive endoscopic gastrojejunal revisions for weight gain following Roux-en-Y gastric bypass: a comparison of endoscopic suturing techniques for stoma reduction. Surg Endosc. 2017;31:2667–77.PubMed
111.
Goldner WS, Stoner JA, Lyden E, et al. Finding the optimal dose of vitamin D following Roux- en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg. 2009;19:173–9.PubMed
112.
Flores L, Moizé V, Ortega E, et al. Prospective study of individualized or high fixed doses of vitamin D supplementation after bariatric surgery. Obes Surg. 2015;25:470–6.PubMed
113.
Oria HE, Moorehead MK. Bariatric Analysis and Reporting Outcome System (BAROS). Obes Surg. 1998;8:487–99.PubMed
114.
Benedix F, Scheidbach H, Arend J, et al. Revision after failed bariatric surgery--review of complications and current therapeutic options. Zentralbl Chir. 2009;134:214–24. discussion 225PubMed
115.
Kolotkin RL, Crosby RD. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-Lite) in a community simple. Qual Life Res. 2002;11:157–71.PubMed
116.
Metadata
Title
A Spanish Society joint SECO and SEEDO approach to the Post-operative management of the patients undergoing surgery for obesity
Authors
R Vilallonga
JL Pereira-Cunill
S Morales-Conde
I Alarcón
I Breton
E Domínguez-Adame
JV Ferrer
A Garcia Ruiz-de-Gordejuela
A Goday
A Lecube
E Martín García-Almenta
MÁ Rubio
FJ Tinahones
PP García-Luna
Publication date
01-12-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 12/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04043-8

Other articles of this Issue 12/2019

Obesity Surgery 12/2019 Go to the issue

Multimedia Article

An Alternative Technique of Reversal of Roux-en-Y Gastric Bypass: the Small Bowel Limb Transposition

Original Contributions

The Edmonton Obesity Staging System Predicts Perioperative Complications and Procedure Choice in Obesity and Metabolic Surgery—a German Nationwide Register-Based Cohort Study (StuDoQ|MBE)

Letter to the Editor

Barrets Oesophagus and Sleeve Gastrectomy

Original Contributions

Non-responders After Gastric Bypass Surgery for Morbid Obesity: Peptide Hormones and Glucose Homeostasis

Original Contributions

Reduction in Thyroid-Stimulating Hormone Correlated with Improved Inflammation Markers in Chinese Patients with Morbid Obesity Undergoing Laparoscopic Sleeve Gastrectomy

Letter to the Editor

Gastroduodenal Intussusception of Remnant Stomach After Gastric Bypass: a Case Report